Comparison of cancer prevalence in patients with neurofibromatosis type 1 at an academic cancer center vs in the general population from 1985 to 2020
JP Landry, KL Schertz, YJ Chiang, AD Bhalla… - JAMA Network …, 2021 - jamanetwork.com
Importance Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is associated
with not only neurofibromas, but also an increased susceptibility to other neoplasms …
with not only neurofibromas, but also an increased susceptibility to other neoplasms …
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020
JP Landry, KL Schertz, YJ Chiang… - JAMA network …, 2021 - pubmed.ncbi.nlm.nih.gov
Importance Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is associated
with not only neurofibromas, but also an increased susceptibility to other neoplasms …
with not only neurofibromas, but also an increased susceptibility to other neoplasms …
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
JP Landry, KL Schertz, YJ Chiang, AD Bhalla… - JAMA Network …, 2021 - europepmc.org
Results Among 1607 patients with NF1, the median (range) age at initial visit was 19 years
(1 month to 83 years) and 840 (52.3%) were female patients. Among 666 patients who …
(1 month to 83 years) and 840 (52.3%) were female patients. Among 666 patients who …
Comparison of Cancer Prevalence in Patients with Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population from 1985 to 2020
JP Landry, KL Schertz, YJ Chiang… - JAMA …, 2021 - mdanderson.elsevierpure.com
Abstract Importance: Neurofibromatosis type 1 (NF1) is a complex genetic disorder that is
associated with not only neurofibromas, but also an increased susceptibility to other …
associated with not only neurofibromas, but also an increased susceptibility to other …
[HTML][HTML] Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020
JP Landry, KL Schertz, YJ Chiang, AD Bhalla… - JAMA Network …, 2021 - ncbi.nlm.nih.gov
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic
Cancer Center vs in the General Population From 1985 to 2020 - PMC Back to Top Skip to …
Cancer Center vs in the General Population From 1985 to 2020 - PMC Back to Top Skip to …
[引用][C] Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020
JP Landry, KL Schertz, YJ Chiang, AD Bhalla, M Yi… - JAMA Network …, 2021 - cir.nii.ac.jp
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic
Cancer Center vs in the General Population From 1985 to 2020 | CiNii Research CiNii 国立 …
Cancer Center vs in the General Population From 1985 to 2020 | CiNii Research CiNii 国立 …
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
JP Landry, KL Schertz, YJ Chiang… - JAMA Network …, 2021 - search.ebscohost.com
This cohort study examines the cancer prevalence and survival outcomes among patients
with neurofibromatosis type 1 vs the general population. Key Points: Question: Do patients …
with neurofibromatosis type 1 vs the general population. Key Points: Question: Do patients …
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020.
JP Landry, KL Schertz, YJ Chiang, AD Bhalla… - JAMA Network …, 2021 - europepmc.org
Results Among 1607 patients with NF1, the median (range) age at initial visit was 19 years
(1 month to 83 years) and 840 (52.3%) were female patients. Among 666 patients who …
(1 month to 83 years) and 840 (52.3%) were female patients. Among 666 patients who …